Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder
Volume: 32, Issue: 5, Pages: 281 - 288
Published: Sep 1, 2017
Abstract
Treatment-emergent suicidal ideation and behavior are ongoing concerns with antidepressants. Vilazodone, currently approved for the treatment of major depressive disorder (MDD) in adults, has also been evaluated in generalized anxiety disorder (GAD). Post-hoc analyses of vilazodone trials were carried out to examine its effects on suicidal ideation and behavior in adults with MDD or GAD. Data were pooled from vilazodone trials in MDD (four...
Paper Details
Title
Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder
Published Date
Sep 1, 2017
Volume
32
Issue
5
Pages
281 - 288
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History